Our own studies demonstrate that patients with CHD-PAH, CTEPH and iPAH show significantly higher percentages of T lymphocytes with the phenotype CD4 + CD200 and CD8+ CD200 in patients with CHD-PAH, CTEPH and iPAH, as compared to controls [131]. This evidence concerns the gene CD8A and pulmonary arterial hypertension.